Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ben Klünder
Observed names:
B. Kluender,
Ben Kluender
Institutions:
AbbVie (United States),
AbbVie (Germany)
Observed institutions:
AbbVie (United States),
AbbVie (Germany)
OpenAlex ID:
A5069999293
Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication
2019
·
Mohamed-Eslam F. Mohamed
, Ben Klünder
, et al.
·
Clinical Pharmacokinetics
·
84
PDF
Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials
2017
·
Ben Klünder
, Mohamed-Eslam F. Mohamed
, et al.
·
Clinical Pharmacokinetics
·
82
PDF
Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I–III Clinical Trials
2019
·
Ben Klünder
, Rajendar K. Mittapalli
, et al.
·
Clinical Pharmacokinetics
·
65
PDF
Exposure–response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis
2018
·
Amit Khatri
, Ben Klünder
, et al.
·
Rheumatology
·
28
Exposure–Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended‐Release Formulation
2019
·
Mohamed‐Eslam F. Mohamed
, Ben Klünder
, et al.
·
Clinical Pharmacology & Therapeutics
·
23
PDF
Exposure–Response Analyses of Upadacitinib Efficacy in Phase II Trials in Rheumatoid Arthritis and Basis for Phase III Dose Selection
2019
·
Mohamed‐Eslam F. Mohamed
, Ben Klünder
, et al.
·
Clinical Pharmacology & Therapeutics
·
21
PDF
Upadacitinib Pharmacokinetics in Japanese Subjects With Rheumatoid Arthritis With the Extended-release Formulation and Comparability to Non-japanese Subjects
2019
·
Mohamed-Eslam Mohamed
, Ben Kluender
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
The value of adalimumab trough levels and clinical assessments in predicting clinical response in patients with established rheumatoid arthritis and an inadequate response to methotrexate
2018
·
J. Smolen
, N. Mostafa
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Upadacitinib Exposure-Response Relationships for Efficacy in Subjects with Moderately to Severely Active Crohn's Disease - Analysis of Celest Study
2018
·
Mohamed-Eslam F. Mohamed
, Ben Kluender
, et al.
·
Gastroenterology
Pharmacokinetics of Adalimumab in Pediatric Subjects with Moderate Versus Severe Crohn's Disease in IMAgINE-1
2016
·
Ravi Shankar P. Singh
, Ben Kluender
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
10
Citation count:
306
H-index:
6
I10-index:
6
Year
Topic
Type